Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (review).

Murata T, Obiri NI, Puri RK.

Int J Mol Med. 1998 Mar;1(3):551-7. Review.

PMID:
9852261
2.

Novel anti-brain tumor cytotoxins specific for cancer cells.

Debinski W, Gibo DM, Obiri NI, Kealiher A, Puri RK.

Nat Biotechnol. 1998 May;16(5):449-53.

PMID:
9592393
3.

Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells.

Murata T, Obiri NI, Debinski W, Puri RK.

Biochem Biophys Res Commun. 1997 Sep 8;238(1):90-4.

PMID:
9299458
4.

Modulation of interleukin (IL)-13 binding and signaling by the gammac chain of the IL-2 receptor.

Obiri NI, Murata T, Debinski W, Puri RK.

J Biol Chem. 1997 Aug 8;272(32):20251-8.

5.
7.

The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor.

Obiri NI, Leland P, Murata T, Debinski W, Puri RK.

J Immunol. 1997 Jan 15;158(2):756-64.

PMID:
8992992
8.

cDNA cloning and characterization of the human interleukin 13 receptor alpha chain.

Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ.

J Biol Chem. 1996 Nov 15;271(46):29265-70.

9.
10.

Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells.

Debinski W, Miner R, Leland P, Obiri NI, Puri RK.

J Biol Chem. 1996 Sep 13;271(37):22428-33.

11.
12.
15.
17.

Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells.

Obiri NI, Siegel JP, Varricchio F, Puri RK.

Clin Exp Immunol. 1994 Jan;95(1):148-55.

18.
19.

Immunostaining of interleukin-4 receptor on human renal cell carcinoma.

Varricchio F, Obiri NI, Haas GP, Puri RK.

Lymphokine Cytokine Res. 1993 Dec;12(6):465-9.

PMID:
8123763
21.

Supplemental Content

Loading ...
Support Center